Italian Regulator Promotes Availability Of Potential COVID-19 Treatments
Remdesivir, Kaletra & Actemra Are In The Frame
Executive Summary
Italy has so far borne the brunt of Europe’s growing coronavirus outbreak. Now it is offering patients the chance to access unauthorized medicines as part of efforts to stem the outbreak.
You may also be interested in...
Where Now For Italy’s Drug Price Transparency Crusade?
The signs suggest that Nicola Magrini, the new director general of the Italian medicines regulator, AIFA, will follow in the footsteps of his predecessor in fighting for transparency in drug pricing.
Post-Brexit UK Risks Being ‘Left Out In The Cold’ As EU Coordinates Action On Shortages
The UK is not alone in experiencing drug shortages, as data from across Europe show, but its departure from the EU makes it more difficult to respond to supply chain pressures, according to new research.
EU Countries Offered Funding To Contribute to African Regulatory Strengthening
Training projects are intended to strengthen the African regulatory environment, boost the capacity of the African Medicines Agency, facilitate regulatory reliance, and increase joint new drug assessments.